KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationCost of RevenueLeasesLong-Term Debt IssuancesMachine, Furnitures, Fixtures & OtherOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Receivables - NetReceivables - Other
Ratios

Twist Bioscience (TWST) Receivables - Other (2018 - 2025)

Twist Bioscience (TWST) has disclosed Receivables - Other for 8 consecutive years, with $12.3 million as the latest value for Q4 2025.

  • Quarterly Receivables - Other rose 569.52% to $12.3 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $12.3 million through Dec 2025, up 569.52% year-over-year, with the annual reading at $3.9 million for FY2025, 89.91% up from the prior year.
  • Receivables - Other for Q4 2025 was $12.3 million at Twist Bioscience, up from $3.9 million in the prior quarter.
  • The five-year high for Receivables - Other was $12.3 million in Q4 2025, with the low at $1.0 million in Q2 2025.
  • Average Receivables - Other over 5 years is $3.9 million, with a median of $3.1 million recorded in 2021.
  • Peak annual rise in Receivables - Other hit 569.52% in 2025, while the deepest fall reached 60.15% in 2025.
  • Over 5 years, Receivables - Other stood at $2.3 million in 2021, then soared by 124.82% to $5.3 million in 2022, then crashed by 52.42% to $2.5 million in 2023, then decreased by 26.52% to $1.8 million in 2024, then skyrocketed by 569.52% to $12.3 million in 2025.
  • According to Business Quant data, Receivables - Other over the past three periods came in at $12.3 million, $3.9 million, and $1.0 million for Q4 2025, Q3 2025, and Q2 2025 respectively.